Controllably Degradable Compositions and Methods

US2018161362A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018161362-A1
Application numberUS-201815882613-A
CountryUS
Kind codeA1
Filing dateJan 29, 2018
Priority dateDec 23, 2013
Publication dateJun 14, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for treating, adhering, or sealing biological tissue are provided. The methods include combining solutions containing a polymer component and a dendrimer component capable of reacting with each other, and at least one of the components includes a substituent capable of photoreversible dimerization that can be reversibly dimerized. Drug delivery compositions and kits containing these two components also are provided.

First claim

Opening claim text (preview).

We claim: 1 . A kit for making an adhesive comprising: a first part which includes a first solution comprising a polymer component, wherein the polymer component comprises a polymer; and a second part which includes a second solution comprising a dendrimer component, wherein the dendrimer component comprises a dendrimer having at least 2 branches with one or more surface groups; wherein at least one of the polymer and the dendrimer is substituted with one or more substituents capable of photoreversible dimerization. 2 . The kit of claim 1 , further comprising a UV light source to activate or deactivate the one or more substituents capable of photoreversible dimerization. 3 . The kit of claim 1 , wherein less than 75% of the surface groups comprise at least one primary or secondary amine. 4 . The kit of claim 1 , wherein 100% of the surface groups comprise at least one primary or secondary amine. 5 . The kit of claim 1 , wherein the polymer comprises dextran. 6 . The kit of claim 1 , wherein the dendrimer comprises a G5 PAMAM dendrimer. 7 . The kit of claim 1 , further comprising an applicator. 8 . The kit of claim 7 , wherein the applicator comprises a multi-compartment syringe. 9 . The kit of claim 8 , wherein the multi-compartment syringe comprises a mixing tip. 10 . The kit of claim 1 , wherein the polymer and the dendrimer are substituted with the one or more substituents capable of photoreversible dimerization. 11 . A drug delivery composition comprising: a polymer component, wherein the polymer component comprises a polymer having three or more aldehyde groups; a dendrimer component, wherein the dendrimer component comprises a dendrimer having at least 2 branches with one or more surface groups; and at least one drug combined with at least one of the polymer component and the dendrimer component; wherein at least one of the polymer and the dendrimer is substituted with one or more substituents capable of photoreversible dimerization. 12 . The composition of claim 11 , wherein 100% of the surface groups comprise at least one primary or secondary amine. 13 . The composition of claim 11 , wherein less than 75% of the surface groups comprise at least one primary or secondary amine. 14 . The composition of claim 11 , wherein the polymer comprises dextran. 15 . The composition of claim 11 , wherein the dendrimer is a G5 PAMAM dendrimer. 16 . The composition of claim 11 , wherein the polymer and the dendrimer are substituted with the one or more substituents capable of photoreversible dimerization.

Assignees

Inventors

Classifications

  • Polysaccharides {(A61L24/043 takes precedence)} · CPC title

  • Use of materials characterised by their function or physical properties · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • A61K31/785Primary

    Polymers containing nitrogen · CPC title

  • Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018161362A1 cover?
Methods for treating, adhering, or sealing biological tissue are provided. The methods include combining solutions containing a polymer component and a dendrimer component capable of reacting with each other, and at least one of the components includes a substituent capable of photoreversible dimerization that can be reversibly dimerized. Drug delivery compositions and kits containing these two…
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification A61K31/785. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).